The groundbreaking approach, BrightMeds' GLP-1 agonist, is quickly gaining traction within the healthcare community for its potential in addressing glucose control and potentially also weight management . This advanced category of pharmaceutical operates by mimicking the body’s inherent GLP-1 hor